Gingicaine Gel, Chocolate Mint
Product Images NDC 10129-034

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Gingicaine Gel, Chocolate Mint (NDC 10129-034). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gingi-pak A Division Of The Belport, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Keep Out Of Reach Of Children (Children Page 001)

This text provides a precautionary statement that advises keeping all Gingicaine Gel products away from children and seeking immediate medical attention if ingested or swallowed by a child.*

FDA Label Image

Contraindications

This text is a warning statement about the use of a product. It states that the product should not be used in patients who have a history of hypersensitivity to ester-type local anesthetics. It also warns against using the product for teething, as well as in infants and children younger than 2 years of age. This suggests that the product is likely a type of local anesthetic medication for pain relief.*

FDA Label Image

Gingicaine Chocolate Mint Jar Label

This is a drug facts sheet for an oral anesthetic product containing 20% benzocaine. The product is intended to minimize pain or discomfort caused by minor dental procedures, gum injuries, canker sores, sore throat, and other minor mouth or gum irritations caused by dentures or orthodontic appliances. The document provides warnings and precautions for safe use, as well as directions for dosage and administration. It also includes information about contraindications and allergy alerts, and advises that the product should not be used by children under the age of two.*

FDA Label Image

Active Ingredient (Gingicaine Active Ingredients 001)

Benzocaine 20% w/v is an active ingredient used as an oral anesthetic.*

FDA Label Image

Allergy Alert (Gingicaine Allergy Alert 002)

This is a warning message regarding the use of the product. It cautions individuals with a history of allergies related to "caine" local anesthetics to not use this product.*

FDA Label Image

Avoid Excessive Heat (Gingicaine Avoid Excessive Heat)

The text advises to avoid exposing something to temperatures exceeding 40 degrees Celsius (104 degrees Fahrenheit) to prevent damage caused by excessive heat.*

FDA Label Image

Consult A Doctor Promptly (Gingicaine Consult A Doctor)

This text provides warning and safety information for a product, advising users to seek medical attention in certain circumstances and to avoid contact with the eyes. It also cautions against exceeding the recommended dosage and warns of the dangers of swallowing excessive amounts.*

FDA Label Image

Dosage And Administration001 (Gingicaine Dosage And Admin 001)

FDA Label Image

Dosage And Administration002 (Gingicaine Dosage And Admin 002)

This text provides instructions for the application of local anesthetic for dental procedures. It recommends using either cotton rolls or saliva ejectors to minimize dilution of the anesthetic and emphasizes the importance of avoiding cross-contamination between patients. It also advises using only the necessary amount of anesthetic and not exceeding the recommended dosage. The product is intended for adults and children 2 years of age and older, and children under 2 should consult a dentist or doctor.*

FDA Label Image

Indications (Gingicaine Indications 001)

This text describes the medical use for a topical anesthetic to numb the mucous membranes of the oropharynx. It helps to reduce pain during various dental procedures such as ulcers, needle punctures, and scaling. In addition, it is useful in patients with an excessive gag reflex when taking impressions or intraoral radiographs.*

FDA Label Image

Precautions (Gingicaine Precaution 001)

This text provides precautions for dentists when using local anesthetics, such as avoiding application on infected or severely traumatized mucosal areas and being cautious with patients who have drug sensitivities, especially to ester-type anesthetics. It also advises dentists to avoid contact with all local anesthetics to prevent sensitization.*

FDA Label Image

Uses (Gingicaine Uses 001)

This text appears to be a description of the possible uses of a product designed to reduce pain or discomfort caused by minor dental procedures, minor gum injuries, canker sores, sore throats, and minor mouth or gum irritations caused by dentures or orthodontic appliances.*

FDA Label Image

Inactive Ingredient (Inactive Ingredient Page 001)

Polyethylene Glycol 3350 and Polyethylene Glycol 400 are chemical compounds commonly used in industrial and medical applications. Polyethylene Glycol 3350 is a laxative often prescribed to relieve constipation, while Polyethylene Glycol 400 is used in topical medications and as a lubricant in various industries. Potassium Sodium Saccharate is a food additive used primarily as a sweetener and is a sodium-potassium salt of saccharin.*

FDA Label Image

Purpose (Purpose Page 001)

"Gingicaine Gel" is a local anesthetic used by dentists before administering an injection. The gel is applied to the patient's gum.*

FDA Label Image

Warnings

This is a warning for a product that can cause a rare but serious condition called methemoglobinemia, which reduces the amount of oxygen carried in blood. Symptoms of this condition include pale, gray, or blue colored skin (cyanosis), headache, rapid heart rate, shortness of breath, dizziness, lightheadedness, fatigue or lack of energy. The product is for external use only and should not be used in children under 2 years of age.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.